CIK 0001178253
- Non-accelerated filer
- Smaller reporting company
SCYNEXIS INC
Sign in to watch- Ticker
- SCYX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 562181648
- Phone
- +1 201-884-5485
- Business address
- 1 EVERTRUST PLAZA, 13TH FLOOR, JERSEY CITY, NJ, 07302-6548
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at $2.23 ($22,300)
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at an average $1.85 ($9,248)
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at $1.61 ($16,100)
- 4 Open-market buy Chief Medical Officer bought 10,000 shares at $1.55 ($15,500)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 20,000 shares at $1.75 ($35,000)
- 4 Open-market buy Chief Executive Officer bought 25,000 shares at $1.69 ($42,250)
- 4 Open-market buy Chief Medical Officer bought 15,000 shares at $1.70 ($25,500)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 9 of 16 · 314 filings